Brazilian Healthtech Memed launches Innovative e-Prescription Platform
Brazil's fastest growing and largest digital health company in terms of user base, volumes & partnerships - has raised US$80 million in the past twelve months and recently launched a set of digitally integrated care pathways as a result of a new strategy implemented by its CEO Joel Rennó Jr. Memed is backed by DNA Capital, the leading healthcare investor in Brazil, and Temasek. About 65% of the proceeds raised are being efficiently allocated to boost technology, product, data science, analytics and clinical intelligence. The new strategy now gains even more momentum with the first platform ever that allows patients to purchase medication online directly from a Memed e-prescription with just a few clicks.
"Imagine how wonderful would be to receive an e-prescription from your physician, open it up on your smartphone, click on a link that automatically takes you to an open platform featuring a whole range of the best pharmacies in Brazil and, with just 2 clicks, purchase your medication online and have it delivered to your home 30 minutes later? That's what we have built to the benefit of our physicians, partners, patients and pharma retailers" adds Joel Rennó Jr.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
